Spectrum of Aspergillus infection in lung transplant recipients: Case series and review of the literature

Chest

Volumn 119, Issue 1, 2001, Pages 169-175

  Mehrad, B ^a   Paciocco, G ^a   Martinez, F J ^a   Ojo, T C ^a   Iannettoni, M D ^a   Lynch, J P ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Aspergillosis; Fungal; Immunocompromised host; Lung diseases; Lung transplantation

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; AZATHIOPRINE; COTRIMOXAZOLE; CYCLOSPORIN A; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; ITRACONAZOLE; METHYLPREDNISOLONE; PREDNISONE;

ADULT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; BRONCHITIS; BRONCHOSCOPY; CYTOMEGALOVIRUS INFECTION; DEBRIDEMENT; FEMALE; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS;

EID: 0035125641     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.119.1.169     Document Type: Article

References (50)

1. Aspergillosis and other systemic mycoses: The growing problem
2. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital
3. Strategies in prevention of invasive pulmonary aspergillosis in immunosuppressed or neutropenic patients
4. Aspergillosis in immunocompromised paediatric patients: Associations with building hygiene, design, and indoor air
5. Epidemiology of nosocomial fungal infections: Invasive aspergillosis and the environment
6. Invasive pulmonary aspergillosis: MRI, CT, and plain radiographic findings and their contribution for early diagnosis
7. Diagnosis of pulmonary infection caused by Aspergillus: Usefulness of respiratory cultures
8. Therapeutic outcome in invasive aspergillosis
9. Invasive aspergillosis in transplant recipients
10. Fungal infections in lung transplant recipients
11. Aspergillus airway colonization and invasive disease after lung transplantation
12. Infectious complications in pulmonary allograft recipients
13. The pulmonary nodule after lung transplantation: Cause and outcome
14. Infectious complications of lung transplantation: Impact of cystic fibrosis
15. Invasive aspergillosis after transplantation
16. Infection in the transplanted and native lung after single lung transplantation
17. Airway stenoses after lung transplantation: Management with expanding metal stents
18. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients
19. Fungal infections in lung and heart-lung transplant recipients: Report of 9 cases and review of the literature
20. Infections in patients with cystic fibrosis following lung transplantation
21. Infectious complications following isolated lung transplantation
22. Pulmonary aspergillosis in cystic fibrosis lung transplant recipients
23. Saprophytic fungal infections and lung transplantation-revisited
24. Prospective study of transbronchial biopsies in the management of heart-lung and single lung transplant patients
25. Opportunistic bronchopulmonary infections after lung transplantation: Clinical and radiographic findings
26. Serodiagnosis and monitoring of Aspergillus infections after lung transplantation
27. Aspergillus infection in single and double lung transplant recipients
28. Aspergillus and lung transplantation
29. Endogenous Aspergillus endophthalmitis after lung transplantation
30. Liposomal amphotericin B in three lung transplant recipients. The Groningen Lung Transplantation Group
31. Aspergillus osteomyelitis after heart-lung transplantation
32. Aspergillus and lung transplant recipients: A mycologic and molecular epidemiologic study
33. Pre-emptive therapy with azoles in lung transplant patients
34. Lung transplantation: Analysis of thirty-six consecutive procedures performed over a twelve-month period; The Washington University Lung Transplant Group
35. Infectious complications in heart-lung transplantation: Analysis of 200 episodes
36. Ulcerative tracheobronchitis after lung transplantation: A new form of invasive aspergillosis
37. Clinical experience in the management of pulmonary opportunist infection and rejection in recipients of heart-lung transplants
38. Allergic bronchopulmonary aspergillosis in lung allograft recipients
39. Recurrence of allergic bronchopulmonary aspergillosis in the posttransplant lungs of a cystic fibrosis patient
40. Treatment of aspergillus-related ulcerative tracheobronchitis in lung transplant recipients
41. Bronchial-pulmonary artery fistula after unilateral lung transplantation: A case report
42. Successful treatment of invasive bronchial aspergillosis after single-lung transplantation
43. Relapsing Aspergillus bronchitis in a double lung transplant patient, successfully treated with a new oral antimycotic agent
44. Aerosol amphotericin B for prevention of invasive pulmonary aspergillosis
45. Use of amphotericin B aerosols for the prevention of pulmonary aspergillosis
46. The toxicity of daily inhaled amphotericin B
47. Deposition of amphotericin B aerosols in pulmonary aspergilloma
48. Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis
49. Antifungal prophylaxis during the early postoperative period of lung transplantation. Valencia Lung Transplant Group
50. Systemic availability of itraconazole in lung transplantation